Curis | CRIS - Выручка от реализации





Продажи Изменить Дата
Alaunos Therapeutics USD 2K 2K 2025-03
Amgen USD 8.62B 1.28B 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Bayer EUR 13.41B 1.97B 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
CSL USD 8.33B 4.79B 2025-12
Curis USD 1.14M 1.41M 2025-12
Eli Lilly USD 19.8B 500M 2026-03
Exelixis USD 610.8M 12.14M 2026-03
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Incyte USD 1.27B 240M 2026-03
Merck USD 16.29B 110M 2026-03
Novartis USD 13.11B 226M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
Takeda JPY 1.09T 100B 2026-03
TG Therapeutics USD 194.8M 2.23M 2026-03
Verastem USD 17.54M 7.53M 2025-12
Xoma USD 25K 5M 2024-09